Astrocytoma progression scoring system based on the WHO 2016 criteria

Diffuse astrocytoma (including glioblastoma) is morbid with a worse prognosis than other types of glioma. Therefore, we sought to build a progression-associated score to improve malignancy and prognostic predictions for astrocytoma. The astrocytoma progression (AP) score was constructed through bioi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhen-Hang, Guan, Yan-Lei, Liu, Qiang, Wang, Yao, Cui, Run, Wang, Yun-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331604/
https://www.ncbi.nlm.nih.gov/pubmed/30643174
http://dx.doi.org/10.1038/s41598-018-36471-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331604/
https://www.ncbi.nlm.nih.gov/pubmed/30643174
http://dx.doi.org/10.1038/s41598-018-36471-4

Ejemplares similares